Sera Prognostics
Dr. Boniface previously served as scientist and program director for a number of biotechnology companies focused on protein discovery and small molecule and immunotherapeutic drug development including Myrexis, Myriad Genetics, Prolexys Pharmaceuticals, and Eos Biotechnology. Dr. Boniface earned his Ph.D. in biochemistry at Albany Medical College and was a postdoctoral scholar in molecular immunology at Stanford University.